1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Inflammatory Bowel Diseases (IBD): new trials by email Literature Review of Inflammatory Bowel Diseases (IBD) trials Research Report on Inflammatory Bowel Diseases (IBD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T - Inflammatory Bowel Diseases (IBD) | Phase 1 / Phase 2 | Not yet recruiting | iCell Gene Therapeutics | 18 | 2026-04-07 | 2026-04-22 |
| Fecal Microbiota Transplantation in Pediatric Patients Fecal Microbiota Transplantation (FMT) - Inflammatory Bowel Diseases (IBD), Crohn's Disease (CD) | Phase 1 | Completed | Children's Mercy Hospital Kansas City | 23 | 2014-03-01 | 2021-02-04 |
Colitis, Ulcerative (2) · Crohn Disease (2) · Inflammatory Bowel Diseases (2)
Colitis (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2)
Fecal Microbiota Transplantation (1)
Children's Mercy Hospital Kansas City (1) · iCell Gene Therapeutics (1)
China (1) · United States (1)
Alka Goyal, MD (1)